A PHASE II TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF THE COMBINATION OF OBINUTUZUMAB BENDAMUSTINE TREATMENT IN PATIENTS WITH RELAPSED /REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA by García‐Marco, J., Baltasar Tello, P., Gonzalez Garcia, E., Ríos Herranz, E., Ramírez Payer, Á., Terol Castera, M., Champ, D., Medina Pérez, Á., Gironella Mesa, M., Rodríguez Fernández, A., Muntañola Prat, A., Suárez Cabrera, A., Puerta Puerta, J., Fernández Zarzoso, M., Rodríguez Calvillo, M., Clavel Piá, J., Dourdil Sahun, V., Ferrá Coll, C., Pérez Persona, E., Marrero Santos, C., Forés Cachón, R., Delgado González, J.

Get full text

LENALIDOMIDE PLUS R‐GDP (R2‐GDP) IN RELAPSED/REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA. PRELIMINARY RESULTS OF THE R2‐GDP‐GOTEL TRIAL by Cruz‐Merino, L., Martín García‐Sancho, A., Nogales Fernández, E., Carnicero González, F., Ríos Herranz, E., Cruz Vicente, F., Rodríguez García, G., Nicolás García, C., Martínez Benaclocha, N., Gumà Padrò, J., Gómez Codina, J., Salar Silvestre, A., Rodríguez Abreu, D., Quero Blanco, C., Labrador Gómez, J., Guirado Risueño, M., Provencio Pulla, M., Rueda Domínguez, A.

Get full text

Philadelphia positive acute lymphoblastic leukemia 16 years after the apparent cure of acute lymphoblastic leukemia. New leukemia or late relapse? by Navarro, JL, de Blas Orlando, J, Rios Herranz, E, Gonzalez Campos, J, Parody, R, Rodriguez Fernandez, JM

Get full text

PB1898 SAFETY AND EFFECTIVENESS OF CHLORAMBUCIL‐OBINUTUZUMAB IN THE FRONT LINE TREATMENT OF UNFIT PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA: REAL‐LIFE DATA FROM ANDALUSIAN LYMPHOI... by Puerta Puerta, J.M., Martín Palanco, V., Badiola, J., Fernández de la Mata, M., Ortiz Pareja, M., Martínez Quesada, M.J., Rodríguez Fernández, A., De la Cruz Vicente, F., Ferrer Chaves, C., Lorente de Uña, S., Moya Rodríguez, R., García Pérez, M.J., García Martín, P., García Cabrera, I.M., Berruezo Salazar, M.J., Fernández Jiménez, D., Ríos Herranz, E.

Request full text

Chronic lymphocytic leukemia with two cellular populations : a biphenotypic or biclonal disease by GONZALEZ-CAMPOS, J, RIOS-HERRANZ, E, DE BLAS-ORLANDO, J. M, MARTIN-NOYA, A, PARODY-RUIZ-BERDEJO, R, RODRIGUEZ-FERNANDEZ, J. M

Get full text

PCN69 PHARMACOECONOMIC ANALYSIS OF THE ADDITION OF RITUXIMAB TO FIRST-LINE CHEMOTHERAPY TREATMENT REGIMENS IN SPANISH PATIENTS WITH ADVANCED FOLLICULAR LYMPHOMA by Rubio-Terrés, C, Gómez-Codina, J, Ríos Herranz, E, Castro, AJ, Varela, C, Ray, JA

Get full text

Multiple myeloma with numerous intranuclear Russell bodies by Martín-Noya, A, Ríos-Herranz, E, Rafel-Ribas, E

Get full text

The irreplaceable image: Primary cutaneous large B-cell lymphoma of the leg with bad evolution by Jiménez-Gonzalo, F J, Medina-Pérez, M, Ríos-Herranz, E

Get full text

Hypereosinophilia and acute lymphocytic leukemia by Rios-Herranz, E., Fores-Cachon, R., Diez-Martin, S. L., Fernandez, M. N.

Get full text

Hypereosinophilia and acute lymphocytic leukemia by Rios-Herranz, E, es-Cachon, R, Diez-Martin, S L, Fernandez, M N

Get full text

Rituximab, Either As Single Agent or in Combination, Is Superior to Other Treatments in Terms of Response Rate and Progression-Free Survival (PFS) in Patients with Splenic Marginal... by Marin-Niebla, Ana, Else, Monica, De la Cruz, Fatima, Batty, Paul, Rios-Herranz, Eduardo, Dearden, Claire E., Espigado, Ildefonso, Simón, Jose Antonio Pérez, Catovsky, Daniel, Matutes, Estella

Get full text